๐Ÿฅ VAERS Vaccine Data Browser

๐Ÿ”’ Privacy & Data Disclaimer

About This Site

This is a public data browser for the Vaccine Adverse Event Reporting System (VAERS). By using this site, you acknowledge and agree to the following:

Data Source & Accuracy

  • Public Data: All data displayed comes from the publicly available VAERS database maintained by the CDC and FDA.
  • No Verification: VAERS accepts all reports without verifying medical accuracy. Reports do not prove causation between vaccines and adverse events.
  • Anyone Can Report: Healthcare providers, patients, family members, and anyone else can submit reports to VAERS.
  • Research Purpose: This data is for transparency, research, and monitoring vaccine safety signals only.

Your Privacy

  • No Personal Data Collection: This site does not collect, store, or track any personal information about visitors.
  • No Cookies: We do not use cookies except for remembering that you've seen this disclaimer (stored locally in your browser).
  • No Analytics: We do not use Google Analytics or any other tracking services.
  • Search Privacy: Your searches and filters are not logged or stored on our servers.
  • Public Data Only: The VAERS data shown here is already public and contains no personally identifiable information.

Medical Disclaimer

  • Not Medical Advice: This tool is for informational purposes only and does not provide medical advice.
  • Consult Healthcare Providers: Always consult qualified healthcare professionals for medical decisions.
  • No Liability: We are not responsible for decisions made based on this data.

Data Interpretation

  • The presence of a report does not mean the vaccine caused the adverse event.
  • Coincidental events are often reported (e.g., a heart attack that happened to occur after vaccination).
  • Serious adverse events must be reported by law, even if unrelated to the vaccine.
  • The database is useful for detecting safety signals that require further investigation.

๐Ÿ“– Help & Search Guide

Column Icons Legend

๐Ÿ’€ Death
๐Ÿฅ Hospitalized
๐Ÿš‘ Emergency Room
โ™ฟ Disability
โš ๏ธ Life Threatening

How to Search

๐Ÿ’ก Search Tips:
  • Select Year: Choose a specific year OR "All Years" to search across all data
  • All Years requires filters: When searching all years, you must select at least one filter (lot number, vaccine type, outcome, etc.) for performance
  • Lot number tracking: Use "All Years" + Lot Number to track lots across multiple years
  • Combine filters: Use multiple filters together to narrow results (e.g., Age + Vaccine Type + Death)
  • VAERS ID: Search for specific report by ID number
  • Age: Enter exact age (e.g., 25) or decimal (e.g., 0.5 for 6 months)
  • State: Enter 2-letter state code (e.g., CA, NY, TX)
  • Vaccine Type: Search partial names (e.g., "COVID19", "FLU", "HPV")
  • Manufacturer: Search by company (e.g., "PFIZER", "MODERNA")
  • Lot Number: Search specific vaccine lot (works great with "All Years")
  • Symptoms: Search for any symptom keyword (e.g., "fever", "rash")
  • Death/Hospitalized: Filter to only show cases with these outcomes

Understanding the Data

  • Reports are unverified: VAERS accepts all reports without medical verification
  • Not proof of causation: A report does not mean the vaccine caused the event
  • Anyone can report: Healthcare providers, patients, and family members can submit reports
  • Multiple vaccines: One report may list multiple vaccines given at the same time
  • Blank fields: Not all fields are required, so some data may be missing

Using the Table

  • Sort columns: Click column headers (ID, Age, Sex, Date, Died) to sort
  • Expand text: Click "More" to see full narrative or symptom text
  • Navigate pages: Use pagination controls at top and bottom of table
  • Export results: Click "๐Ÿ“ฅ Export CSV" to download filtered data (max 10,000 records)

๐Ÿ’ก Frequently Asked Questions (FAQ)

What is this site?

๐Ÿฅ VAERS Vaccine Data Browser is an independent, third-party data browser for publicly available VAERS (Vaccine Adverse Event Reporting System) data.

Important: This site is NOT affiliated with, endorsed by, or operated by the CDC, FDA, or any government agency. We are an independent service that makes public VAERS data easier to search and analyze.

What is VAERS?

VAERS (Vaccine Adverse Event Reporting System) is a national early warning system established in 1990 to detect possible safety problems with vaccines. It's co-managed by the CDC (Centers for Disease Control and Prevention) and FDA (Food and Drug Administration).

VAERS accepts and analyzes reports of adverse events (possible side effects) after a person has received a vaccination.

Official VAERS website: vaers.hhs.gov

Is this data HIPAA compliant?

Yes, absolutely. All VAERS data displayed here is:

  • Publicly available - Published by the CDC/FDA on their official website
  • De-identified - Contains no personally identifiable information (names, addresses, contact info removed)
  • Legally accessible - Available to researchers, media, and the general public under FOIA (Freedom of Information Act)
  • Not protected health information - Once de-identified and published by the government, it's no longer covered by HIPAA restrictions

This site displays the same public data available at vaers.hhs.gov/data.

Why does this site exist?

We believe in transparency and public access to health data. While the CDC/FDA provide VAERS data, their official site:

  • Is difficult to search and filter
  • Requires downloading large CSV files and technical knowledge
  • Is not user-friendly for the average person

This independent site makes the same publicly available data easier to search, filter, and understand for researchers, journalists, healthcare workers, and concerned citizens.

Where does the data come from?

All data is downloaded directly from the official CDC/FDA VAERS website at vaers.hhs.gov/data.

The data is:

  • Publicly released by the CDC/FDA every week
  • Available as downloadable CSV files
  • Imported into this site's database for easier searching
  • Displayed exactly as provided (no modifications or filtering)

This site does not collect, modify, or add to the official VAERS data.

My vaccine lot number matches one with deaths/serious events - should I be worried?

Important context:

  • VAERS reports do NOT prove causation - A report means an event occurred after vaccination, but doesn't mean the vaccine caused it
  • Anyone can report - Reports are not verified for medical accuracy before being published
  • Coincidences happen - When millions of people get vaccinated, some will experience unrelated medical events afterward
  • Large lot numbers - Popular vaccines may have hundreds of thousands of doses from one lot number
  • More vaccinations = more reports - Lots used widely will naturally have more reports

What to do:

  • Don't panic - VAERS data requires expert analysis to interpret
  • Talk to your doctor if you have concerns
  • Check official CDC/FDA safety communications for genuine safety signals
  • Remember: billions of vaccine doses have been safely administered

Can I trust VAERS data?

VAERS is valuable but has limitations:

Strengths:

  • โœ… Early warning system for potential safety signals
  • โœ… Open and transparent - publicly accessible
  • โœ… Accepts all reports regardless of likelihood of causation
  • โœ… Monitored by CDC/FDA experts who investigate concerning patterns

Limitations:

  • โš ๏ธ Reports are unverified - not investigated before publication
  • โš ๏ธ Cannot determine if vaccine caused the event
  • โš ๏ธ Underreporting - not all adverse events are reported
  • โš ๏ธ Overreporting - coincidental events may be reported
  • โš ๏ธ Incomplete data - not all fields are required

Bottom line: VAERS is an important tool for safety monitoring, but individual reports should not be used as proof that a vaccine caused harm.

What are "adverse events"?

An adverse event is any undesirable health occurrence that happens after vaccination, including:

  • Common reactions: Sore arm, mild fever, fatigue (usually expected)
  • Serious events: Hospitalization, disability, life-threatening illness, death
  • Coincidental events: Medical conditions that would have occurred anyway

Important: An adverse event doesn't mean the vaccine caused it - only that it occurred after vaccination. Many reported events are coincidental or unrelated.

Why are some lot numbers listed multiple times?

This is normal and expected! A person may receive multiple doses of the same vaccine from the same lot number:

  • COVID vaccines require 2-3 doses
  • HPV, Hepatitis B, and other vaccines have multi-dose schedules
  • Each dose is recorded as a separate entry

Example: Person receives Pfizer COVID dose 1 (lot ABC123) and dose 2 (lot ABC123) - lot ABC123 appears twice in their report.

How often is this data updated?

The CDC/FDA releases new VAERS data every Friday. This site is typically updated:

  • Weekly or bi-weekly for recent data
  • Check the available years to see what data is currently loaded
  • During updates, the site may be in maintenance mode temporarily

Where can I learn more?

โš ๏ธ DISCLAIMER: This data is from the Vaccine Adverse Event Reporting System (VAERS). Reports do not establish causation between vaccines and adverse events. Anyone can submit a report, and reports are not verified. This is raw data for transparency and research purposes only.
34,052
Total Reports (2025)
500
Deaths Reported
1,634
Hospitalizations
30
ER Visits
1,191
Disabilities
570
Life Threatening
๐Ÿ”„ Reset ๐Ÿ“ฅ Export CSV
ID Age Sex State Date โ–ผ Onset Days Vaccine Manufacturer Lot # Symptoms Narrative ๐Ÿ’€ ๐Ÿฅ ๐Ÿš‘ โ™ฟ โš ๏ธ
2832551 39 F IN 03/21/2025 HPV9
 MERCK & CO. INC.
 y014059
Lymphadenopathy, Mass Lymphadenopathy, Mass
Lump in left arm with lymphadenopathy on same side starting on day of injection, worsening until tod... Lump in left arm with lymphadenopathy on same side starting on day of injection, worsening until today 3/21. Will treat moving forward with medrol dose pack and if needed antibiotics if infection suspected after steroids. More
2832552 75 F GA 03/21/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
Inappropriate schedule of product administration, Injection site reaction Inappropriate schedule of product administration, Injection site reaction
Patient was contacted by the pharmacy to inform her that her second dose was sooner than the recomm... Patient was contacted by the pharmacy to inform her that her second dose was sooner than the recommendation by the CDC. She was informed that because of an early dose, she is more likely to experience side effects or adverse events. At this time, patient stated that she did experience side effects that she didn?t have on dose one. She stated that she developed a rash on her arm. It was larger than just at the injection site. She stated that it did not hurt or itch and so she did not seek medical attention. It resolved within a couple of days on its own. More
2832553 11 F KY 03/21/2025 HEPA
 MERCK & CO. INC.
 X021563
Inappropriate schedule of product administration, No adverse event Inappropriate schedule of product administration, No adverse event
Patient had received first dose 9/13/24 therefore the 2nd dose was given 5 days too soon. No signs/s... Patient had received first dose 9/13/24 therefore the 2nd dose was given 5 days too soon. No signs/symptoms of any adverse affects post vaccination administration More
2832554 4 F KS 03/21/2025 DTAPIPV
 GLAXOSMITHKLINE BIOLOGICALS
 42Y93
Vaccination site erythema, Vaccination site swelling Vaccination site erythema, Vaccination site swelling
Large area of erythema and small amount of swelling localized around the vaccine site starting 1 day... Large area of erythema and small amount of swelling localized around the vaccine site starting 1 day after vaccination. More
2832555 31 F CA 03/21/2025 VARCEL
 MERCK & CO. INC.
 YO1 3073
Contraindication to vaccination, No adverse event Contraindication to vaccination, No adverse event
Applicant has history of LUpus and reveived Varicella vaccine. No adverse reactions noted at this ti... Applicant has history of LUpus and reveived Varicella vaccine. No adverse reactions noted at this time. Instructed to monitor for next 21 days. Instructed to notify primary care provider and work clinic of any adverse reactions. ie.e fever,rash. More
2832556 66 M GA 03/21/2025 FLU3
VARZOS
 SANOFI PASTEUR
GLAXOSMITHKLINE BIOLOGICALS
 U8524DA
52F7M
Asthenia, Neuromyelitis optica spectrum disorder; Asthenia, Neuromyelitis optica... Asthenia, Neuromyelitis optica spectrum disorder; Asthenia, Neuromyelitis optica spectrum disorder More
Patient has Neuromyelitis Optica Spectrum Disorder that is well managed at this time and at the time... Patient has Neuromyelitis Optica Spectrum Disorder that is well managed at this time and at the time of vaccine. Patient states that he soon started experiencing weakness in both legs and had 2 serious falls r/t the weakness. Patient states that he spoke with his neurologist at that time and has a follow-up appointment in 1 week. Patient states that he returned to baseline after 2 weeks. More
2832557 8 M SC 03/21/2025 COVID19
FLU3
HEPA
IPV
TDAP
 MODERNA
SEQIRUS, INC.
GLAXOSMITHKLINE BIOLOGICALS
SANOFI PASTEUR
GLAXOSMITHKLINE BIOLOGICALS
 3042999
391439
T5727
W1C831M
3RE73
Extra dose administered, No adverse event; Extra dose administered, No adverse e... Extra dose administered, No adverse event; Extra dose administered, No adverse event; Extra dose administered, No adverse event; Extra dose administered, No adverse event; Extra dose administered, No adverse event More
First MMR 9/22/2023 Second MMR 11/9/2023 Third MMR 3/18/25 - dose given inadvertently. No adverse re... First MMR 9/22/2023 Second MMR 11/9/2023 Third MMR 3/18/25 - dose given inadvertently. No adverse reaction noted. More
2832558 64 M FL 03/21/2025 PNC20
 PFIZER\WYETH
 LX4482
Extra dose administered, Pain in extremity Extra dose administered, Pain in extremity
Patient received an additional dose of Prevnar 20. His initial dose was 9/7/2023 and pharmacist on d... Patient received an additional dose of Prevnar 20. His initial dose was 9/7/2023 and pharmacist on duty provided additional dose on 3/20/2025 not meeting timeline CDC guidelines. Patient states his arm is sore from injection but no other symptoms. More
2832559 66 F TN 03/21/2025 TDAP
 GLAXOSMITHKLINE BIOLOGICALS
 L5229
Extra dose administered, Pain in extremity Extra dose administered, Pain in extremity
Patient received additional dose of Boostrix on 3/20/2025, previous dose was on 5/15/2024. CDC guide... Patient received additional dose of Boostrix on 3/20/2025, previous dose was on 5/15/2024. CDC guidelines not met of 8-10 year apart from 1st dose. Patient arm was sore but no other symptoms. More
2832561 1.83 F ID 03/21/2025 MMRV
 MERCK & CO. INC.
 Y015357
No adverse event, Product administered to patient of inappropriate age No adverse event, Product administered to patient of inappropriate age
No adverse effect at this time. Patient was younger than recommended age. No adverse effect at this time. Patient was younger than recommended age.
2832563 F TN 03/21/2025 DTAP
 GLAXOSMITHKLINE BIOLOGICALS
 BH57H
Injection site pruritus, Injection site rash, Injection site swelling Injection site pruritus, Injection site rash, Injection site swelling
RASH AND SWELLING TO INJECTION SITE, ITCHY. GAVE ORAL BENADRYL AND SENT RX FOR BENADRYL ONITMENT RASH AND SWELLING TO INJECTION SITE, ITCHY. GAVE ORAL BENADRYL AND SENT RX FOR BENADRYL ONITMENT
2832564 13 M FL 03/21/2025 HEPA
HPV9
 GLAXOSMITHKLINE BIOLOGICALS
MERCK & CO. INC.
 DN273
Y014510
Dizziness, Pallor; Dizziness, Pallor Dizziness, Pallor; Dizziness, Pallor
Pt here today for immunizations. Pt received havrix and gardasil. After vaccines were administered p... Pt here today for immunizations. Pt received havrix and gardasil. After vaccines were administered pt began to turn pale and reported dizziness and this medical assistant helped pt into a supine position to avoid a fall and or injury. As soon as pt was laid down pt immediately reported feeling better and regained color in his face. After providing verbal reassurance pt was instructed to remain lying down and vitals were as followed: 114/64 BP, 86 HR, 18 RR, 98% O2. After 30 minutes pt was A&O x 4 and reported feeling better and expressed wanting to go home. Pt was then discharged. More
2832565 29 F CA 03/21/2025 TDAP
 GLAXOSMITHKLINE BIOLOGICALS
 2A755
Rash Rash
Patient developed a rash. Provider verified it was a reaction to the vaccine. Patient developed a rash. Provider verified it was a reaction to the vaccine.
2832566 44 M WA 03/21/2025 COVID19
COVID19
COVID19
COVID19
COVID19
COVID19
COVID19
COVID19
COVID19
COVID19
COVID19
COVID19
COVID19
COVID19
COVID19
COVID19
COVID19
COVID19
 MODERNA
MODERNA
MODERNA
MODERNA
MODERNA
MODERNA
MODERNA
MODERNA
MODERNA
MODERNA
MODERNA
MODERNA
MODERNA
MODERNA
MODERNA
MODERNA
MODERNA
MODERNA
 044B21A
044B21A
044B21A
044B21A
044B21A
044B21A
044B21A
044B21A
044B21A
006C21A
006C21A
006C21A
006C21A
006C21A
006C21A
006C21A
006C21A
006C21A
Aldolase, Arthralgia, Autoimmune disorder, Blood calcium, Blood creatine phospho... Aldolase, Arthralgia, Autoimmune disorder, Blood calcium, Blood creatine phosphokinase; Blood magnesium, Blood phosphorus, Blood test, Bone densitometry, C-reactive protein; Chest X-ray, Chest pain, Computerised tomogram heart, Differential white blood cell count, Echocardiogram; Electrocardiogram, Exercise tolerance decreased, Eye haemorrhage, Fibrin D dimer, Full blood count; Glycosylated haemoglobin, Immunoassay, Impaired work ability, Injection site pain, Lipids; Loss of consciousness, Loss of personal independence in daily activities, Low density lipoprotein, Magnetic resonance imaging spinal, Magnetic resonance imaging thoracic; Mast cell activation syndrome, Metabolic function test, Muscle spasms, Muscle twitching, Myalgia; Petechiae, Platelet count, Red blood cell sedimentation rate, SARS-CoV-2 antibody test, Scan myocardial perfusion; Scan with contrast, Serum ferritin, Spinal X-ray, Thrombosis; Aldolase, Arthralgia, Autoimmune disorder, Blood calcium, Blood creatine phosphokinase; Blood magnesium, Blood phosphorus, Blood test, Bone densitometry, C-reactive protein; Chest X-ray, Chest pain, Computerised tomogram heart, Differential white blood cell count, Echocardiogram; Electrocardiogram, Exercise tolerance decreased, Eye haemorrhage, Fibrin D dimer, Full blood count; Glycosylated haemoglobin, Immunoassay, Impaired work ability, Injection site pain, Lipids; Loss of consciousness, Loss of personal independence in daily activities, Low density lipoprotein, Magnetic resonance imaging spinal, Magnetic resonance imaging thoracic; Mast cell activation syndrome, Metabolic function test, Muscle spasms, Muscle twitching, Myalgia; Petechiae, Platelet count, Red blood cell sedimentation rate, SARS-CoV-2 antibody test, Scan myocardial perfusion; Scan with contrast, Serum ferritin, Spinal X-ray, Thrombosis More
The week following both vaccinations, I had an extremely sore arm/shoulder at the injection site. O... The week following both vaccinations, I had an extremely sore arm/shoulder at the injection site. Once my arm soreness subsided, I did not have any noticeable serious health issues until July 6th of 2022. On that date, following swimming at the gym, I developed severe chest pain that lasted about 10 to 15 minutes. This symptom re-occurred several times during physical activity. I went to urgent care following my third chest pain incident. Nothing was found at that time, but I was referred to a cardiologist. The cardiologist gave me a clean bill of health and advised I go back to full exercise. I continued to have chest pain with exercise and limited my activity significantly. In October 2022, I was walking slowly on a treadmill and had a bout of severe case of chest pain, muscle spasms all around my torso, passed out, had petechiae in my face and a burst vessel in my eye. I consulted with my primary care doctor, who had no idea what was happening and referred me to a sports medicine doctor. The sports medicine doctor did not find anything wrong with me to explain my symptoms, neither did a neurosurgery doctor. My symptoms continued to worsen with escalating muscle twitching, soreness, spasms, and occasional chest pain (from physical activity). The muscle twitching and soreness did not correlate to any known physical activity. I was beginning to have a hard time working, sitting in a chair, and doing the most basic of everyday tasks. I met with a vaccine injury and long-COVID care clinic doctor and after several visits and tests was advised I very likely have a vaccine injury. I have been diagnosed with autoimmune disease, including MCAS, and widespread fibrin micro-blood clotting. My symptoms have improved over the past two years with the help of many therapies/protocols, including continued medication, supplementation, and life-style changes, but my twitching and muscle soreness continues to be a constant struggle with more acute flare-ups periodically. More
โœ“
2832567 68 F FL 03/21/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 wcf3021
Dyspnoea, Hypotension Dyspnoea, Hypotension
Resident was given epinephrine x 1 dose IM .and place on oxygen due to shortness of breath. Resident... Resident was given epinephrine x 1 dose IM .and place on oxygen due to shortness of breath. Resident had symptoms of SOB, and low BP. More
2832568 15 F MD 03/21/2025 MMR
 MERCK & CO. INC.
 Y003499
Hyperhidrosis, Pallor, Syncope, Tinnitus Hyperhidrosis, Pallor, Syncope, Tinnitus
Patient experienced diaphoresis, syncope, and pallor. Patient complains of head ringing. Pt had syn... Patient experienced diaphoresis, syncope, and pallor. Patient complains of head ringing. Pt had syncopal episode lasting about 2 minutes. Client feet elevated and provided water once alert and oriented to person, place, time, and situation. Client admits to fasting prior to vaccine administration. Patient's mother requested ambulance to be made aware, EMS called arrived on scene about 5-8 mins after call. Upon EMS arrival patient alert and oriented to person, place, time and situation, VS and FS obtained by EMS. Patient's mother declined hospital transport, signed with EMS. Client ambulated from clinic alert and oriented to person, place, time and situation with steady gait. More
2832569 23 M TX 03/21/2025 TDAP
 SANOFI PASTEUR
 u8122aa
Syncope Syncope
Fainted---monitored, gave water, offered medical attention---patient refused medical attention, sai... Fainted---monitored, gave water, offered medical attention---patient refused medical attention, said he felt better and left with the person he arrived with. More
2832570 73 M NJ 03/21/2025 CHIK
HEPA
IPV
TDAP
TYP
 VALNEVA USA, INC.
MERCK & CO. INC.
SANOFI PASTEUR
GLAXOSMITHKLINE BIOLOGICALS
SANOFI PASTEUR
 24B011
Y017625
Y1A201M
U8352AA
W1A991M
Angiogram, Concussion, Diarrhoea, Loss of consciousness, Skin laceration; Angiog... Angiogram, Concussion, Diarrhoea, Loss of consciousness, Skin laceration; Angiogram, Concussion, Diarrhoea, Loss of consciousness, Skin laceration; Angiogram, Concussion, Diarrhoea, Loss of consciousness, Skin laceration; Angiogram, Concussion, Diarrhoea, Loss of consciousness, Skin laceration; Angiogram, Concussion, Diarrhoea, Loss of consciousness, Skin laceration More
This client was seen at facility on Fri 2/7. He elected to receive Ixchiq, Hep A #1, Typhoid Vi, TDA... This client was seen at facility on Fri 2/7. He elected to receive Ixchiq, Hep A #1, Typhoid Vi, TDAP and polio on that day. He was fine over the weekend. Took his normal morning walk on Monday morning. Monday evening, he had laid down on the couch. When he went to get up, he passed out. He tried to get up again and passed out and hit his head on a lamp which broke glass and cut his forehead. He crawled into bed and went to sleep. He was in and out of it on Tuesday, feeling "concussed" with diarrhea. His family caught up with him on Wednesday and took him to the ER. More
2832571 76 F FL 03/21/2025 PNC20
 PFIZER\WYETH
 LX4482
Extra dose administered, No adverse event Extra dose administered, No adverse event
Patient did not have an adverse reaction. She just received a second dose of Prevnar 20 when she had... Patient did not have an adverse reaction. She just received a second dose of Prevnar 20 when she had already received a dose two years ago. More
2832572 66 F PA 03/21/2025 COVID19
 MODERNA
 3043823
Expired product administered Expired product administered
Administration error. Vaccine was 3 days past expiration date Administration error. Vaccine was 3 days past expiration date
2832573 18 F MI 03/21/2025 COVID19
 MODERNA
 B0005
Expired product administered Expired product administered
The use by date was 3/13/25. The patient was given the vaccine on 3/17/25. The use by date was 3/13/25. The patient was given the vaccine on 3/17/25.
2832574 59 M MN 03/21/2025 PNC20
 PFIZER\WYETH
 HN5978
Back pain, Gait disturbance, Hypoaesthesia, Hypoaesthesia oral Back pain, Gait disturbance, Hypoaesthesia, Hypoaesthesia oral
8/2/24 started to notice numbness of lower extremities, gradually worsened spreading upward, because... 8/2/24 started to notice numbness of lower extremities, gradually worsened spreading upward, because unable to ambulate easily and was having low back pain, numbness continued to spread to involve the upper extremities and down around the lips. More
โœ“
2832575 29 F VA 03/21/2025 FLU3
 SANOFI PASTEUR
 ut8514ka
Extra dose administered, No adverse event Extra dose administered, No adverse event
Member given extra dose of flu shot. Member given flu shot outside of facility on 2/05/25 and given ... Member given extra dose of flu shot. Member given flu shot outside of facility on 2/05/25 and given again today in our office 3/21/25. No adverse reactions noted. More
2832576 9 F KY 03/21/2025 HEPA
 MERCK & CO. INC.
 X021563
Inappropriate schedule of product administration, No adverse event Inappropriate schedule of product administration, No adverse event
Patient was given the vaccine 5 days too early, no signs or symptoms or any adverse affects noted Patient was given the vaccine 5 days too early, no signs or symptoms or any adverse affects noted
2832577 8 M UT 03/21/2025 COVID19
 PFIZER\BIONTECH
 lm2045
Expired product administered, No adverse event Expired product administered, No adverse event
Gave this vaccine after the Beyond use date by accident. No adverse event reported Gave this vaccine after the Beyond use date by accident. No adverse event reported
2832578 6 F UT 03/21/2025 COVID19
 PFIZER\BIONTECH
 UT8496MA
Expired product administered, No adverse event Expired product administered, No adverse event
NO ADVERSE EVENT. EXPIRED VACCINE ADMINISTERED. NO ADVERSE EVENT. EXPIRED VACCINE ADMINISTERED.
2832579 10 M UT 03/21/2025 COVID19
 PFIZER\BIONTECH
 LM2045
Expired product administered, No adverse event Expired product administered, No adverse event
NO ADVERSE EVENT. EXPIRED VACCINE GIVEN NO ADVERSE EVENT. EXPIRED VACCINE GIVEN
2832580 7 M UT 03/21/2025 COVID19
 PFIZER\BIONTECH
 LM20458
Expired product administered, No adverse event Expired product administered, No adverse event
NO ADVERSE EVENT. EXPIRED VACCINE ADMINISTERED NO ADVERSE EVENT. EXPIRED VACCINE ADMINISTERED
2832581 11 M UT 03/21/2025 COVID19
 PFIZER\BIONTECH
 UT8408KA
Expired product administered, No adverse event Expired product administered, No adverse event
NO ADVERSE EVENT. EXPIRED VACCINE GIVEN NO ADVERSE EVENT. EXPIRED VACCINE GIVEN
2832582 10 F UT 03/21/2025 COVID19
 PFIZER\BIONTECH
 LM2045
Expired product administered, No adverse event Expired product administered, No adverse event
NO ADVERSE EVENT. EXPIRED VACCINE ADMINISTERED NO ADVERSE EVENT. EXPIRED VACCINE ADMINISTERED
2832583 17 M PA 03/21/2025 MENB
 PFIZER\WYETH
 LF5302
Urticaria Urticaria
Urticaria/Hives-diffuse. Treated with diphenhydramine, Cetirizine. Prednisone Urticaria/Hives-diffuse. Treated with diphenhydramine, Cetirizine. Prednisone
2832584 45 F 03/21/2025 IPV
 SANOFI PASTEUR
 X1C891M
Wrong product administered Wrong product administered
Polio received instead of MMR Polio received instead of MMR
2832585 70 F TX 03/21/2025 RSV
RSV
 GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS

Body temperature increased, Breath sounds abnormal, Cough, Dyspnoea, Oedema peri... Body temperature increased, Breath sounds abnormal, Cough, Dyspnoea, Oedema peripheral; Painful respiration, Skin discolouration More
I got the shot and then a day later my shoulder swelled. 2-3 days later i got a black and blue mark... I got the shot and then a day later my shoulder swelled. 2-3 days later i got a black and blue mark it was painful but im on blood thinners so i didnt think much of it . 2 weeks ago i got a cough but its pollen season but then i started having issues breathing and a temp at night every night. And so i have an appointment next tues but i had so much trouble breathing i went yesterday they check my oxygen level i was at 91, they listened to my lungs and they heard no air flow at the bottom of my lungs but the top wasn't doing well either, They put me on oxygen for 20 mins and it went up to 94%, they put me on two meds. I still feel like today i cant get a full breath, everything hurts in the lung area but i have only had 2 pills so far. More
2832586 3 F NJ 03/21/2025 HEPA
 MERCK & CO. INC.
 Y008338
Extra dose administered Extra dose administered
Patient was given third dose of Hepatitis A in error. Provider believed pt needed her second dose, b... Patient was given third dose of Hepatitis A in error. Provider believed pt needed her second dose, but she had already received two doses on 04-07-2023 and 10-23-2023. Dose given on 3/20/25 was extra dose. Pt is doing well More
2832587 59 M PA 03/21/2025 VARZOS
 GLAXOSMITHKLINE BIOLOGICALS
 Unknown
Urticaria Urticaria
The first SHINGRIX vaccine was administered 10/23/2024. I did not notice any changes. A few days aft... The first SHINGRIX vaccine was administered 10/23/2024. I did not notice any changes. A few days after 12/27/2024 SHINGRIX vaccine I noticed hives in areas I don't normally get hives. The were presented on thighs and ankles. I read this is not uncommon. It was on 1/17/2025 that I noticed I had NOT gotten any of my usual dermatographia hives since the second dose. On 1/20/2025 I saw my first dermatographia hive in the usual places. I still see hives on occasion but only about once ever 2 weeks. This is a decrease from the multiple times a week prior to the SHINGRIX vaccine. I made note in doctor site portal but did not visit medical staff. More
2832588 59 F WY 03/21/2025 MMR
 MERCK & CO. INC.
 Y010372
Flushing, Skin warm, Throat irritation Flushing, Skin warm, Throat irritation
Advised patient to report to the emergency room for moderate facial flushing, hot ears and scratchy ... Advised patient to report to the emergency room for moderate facial flushing, hot ears and scratchy throat. More
2832589 11 M AR 03/21/2025 MNQ
TDAP
 NOVARTIS VACCINES AND DIAGNOSTICS
GLAXOSMITHKLINE BIOLOGICALS
 7gf79
CX4H2
Mass, Rash, Swelling; Mass, Rash, Swelling Mass, Rash, Swelling; Mass, Rash, Swelling
Received TdaP and menveo one day prior to onset. Localized swelling, mass and lump, unspecified.. I... Received TdaP and menveo one day prior to onset. Localized swelling, mass and lump, unspecified.. It began yesterday. It is of moderate intensity. This is the first episode. The typical duration of an episode is the majority of the day. There are no obvious aggravating factors. Nothing relieves the symptoms. Associated symptoms include rash. He denies abdominal pain, arthralgias, chest pain, chills, constipation, cough, diarrhea, dysuria, fever, headache, hematuria, jaundice, melena, myalgias, nausea, palpitations, paresthesias, red bloody stools, sore throat, sweats, tachycardia, vomiting or weight loss. More
2832590 7 F IL 03/21/2025 DTAP
 GLAXOSMITHKLINE BIOLOGICALS
 9pt2f
Product administered to patient of inappropriate age Product administered to patient of inappropriate age
patient is 7 and was mistakenly given Dtap instead of Tdap patient is 7 and was mistakenly given Dtap instead of Tdap
2832591 54 M KS 03/21/2025 PNC21
 MERCK & CO. INC.
 Y019158
Fatigue, Lymphadenopathy, Pain in extremity Fatigue, Lymphadenopathy, Pain in extremity
Patient had a sore arm the next day but noticed the swollen lymph nodes 2 days after receiving the v... Patient had a sore arm the next day but noticed the swollen lymph nodes 2 days after receiving the vaccine. He has also been fatigued. More
2832592 1 F WA 03/21/2025 HIBV
 SANOFI PASTEUR
 UK111AA
Extra dose administered Extra dose administered
Combo vaccine Vaxelis administered as well which contains HIB. Additional HIB vaccine given at the s... Combo vaccine Vaxelis administered as well which contains HIB. Additional HIB vaccine given at the same time. More
2832603 1 GA 03/21/2025 VARCEL
 MERCK & CO. INC.
 Y015101
No adverse event, Product storage error No adverse event, Product storage error
HCP called to report T/E for VARIVAX (case#02756055). VARIVAX was administered to 1 patient on 2/19/... HCP called to report T/E for VARIVAX (case#02756055). VARIVAX was administered to 1 patient on 2/19/2025 to a 12 month old patient. Permission given to contact HCP. No other information was known or provided by HCP. No additional AE reported. No PQC.; HCP called to report T/E for VARIVAX (case#02756055). VARIVAX was administered to 1 patient on 2/19/2025 to a 12 month old patient. Permission given to contact HCP. No other information was known or provided by HCP. No additional AE reported. No PQC.; Information has been received from Business Partner/CRO on 19-Feb-2025. This spontaneous report was received from a/an Other health professional and refers to a(n) 12-month-old patient of unknown gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 19-Feb-2025, the patient started therapy with Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX REFRIGERATOR STABLE), Solution for injection (lot #Y015101, expiration date: 06-Sep-2026), dose number 1, (1st dose),. On 19-Feb-2025, the patient started therapy with sterile diluent (MERCK STERILE DILUENT), Solution for injection (1st dose), (indication, expiration date, and lot # were not reported). The patient started therapy with Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX REFRIGERATOR STABLE), for the treatment of prophylaxis. On 19-Feb-2025, the patient experienced HCP called to report T/E for VARIVAX (case#02756055). VARIVAX was administered to 1 patient on 2/19/2025 to a 12 month old patient. Permission given to contact HCP. No other information was known or provided by HCP. No additional AE reported. No PQC.. On 19-Feb-2025, the patient experienced HCP called to report T/E for VARIVAX (case#02756055). VARIVAX was administered to 1 patient on 2/19/2025 to a 12 month old patient. Permission given to contact HCP. No other information was known or provided by HCP. No additional AE reported. No PQC.. At the reporting time, the outcome of HCP called to report T/E for VARIVAX (case#02756055). VARIVAX was administered to 1 patient on 2/19/2025 to a 12 month old patient. Permission given to contact HCP. No other information was known or provided by HCP. No additional AE reported. No PQC. and HCP called to report T/E for VARIVAX (case#02756055). VARIVAX was administered to 1 patient on 2/19/2025 to a 12 month old patient. Permission given to contact HCP. No other information was known or provided by HCP. No additional AE reported. No PQC. was unknown. The action taken with sterile diluent and Varicella Virus Vaccine Live (Oka-Merck) was reported as not applicable. More
2832606 F VA 03/21/2025 PNC21
 MERCK & CO. INC.
 Y013009
Influenza like illness, Injection site erythema, Injection site pain, Injection ... Influenza like illness, Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth More
HCP reports patient received CAPVAXIVE in her Left Deltoid on 3/7/2025 and on 3/8/2025 developed a l... HCP reports patient received CAPVAXIVE in her Left Deltoid on 3/7/2025 and on 3/8/2025 developed a large area of redness and warmth around the injection site. HCP states minimal swelling and mild tenderness. Patient also complained of flu like sympt; HCP reports patient received CAPVAXIVE in her Left Deltoid on 3/7/2025 and on 3/8/2025 developed a large area of redness and warmth around the injection site. HCP states minimal swelling and mild tenderness. Patient also complained of flu like sympt; HCP reports patient received CAPVAXIVE in her Left Deltoid on 3/7/2025 and on 3/8/2025 developed a large area of redness and warmth around the injection site. HCP states minimal swelling and mild tenderness. Patient also complained of flu like sympt; HCP reports patient received CAPVAXIVE in her Left Deltoid on 3/7/2025 and on 3/8/2025 developed a large area of redness and warmth around the injection site. HCP states minimal swelling and mild tenderness. Patient also complained of flu like sympt; Patient also complained of flu like symptoms; This spontaneous report has been received from a pharmacist regarding a 78-year-old female patient. The patient's medical history, concurrent conditions, and concomitant therapies were not reported. On 07-MAR-2025, the patient started therapy with Pneumococcal 21-valent Conjugate Vaccine (CAPVAXIVE), as a single dose, administered intramuscularly in the left deltoid as immunization (lot number reported as Y013009, which has been verified as valid, expiration date reported and validated as 17-NOV-2025) (strength, dose, and vaccination scheme were not reported). On 08-MAR-2025, the patient developed a large area of redness and warmth around the injection site (Vaccination site erythema, Vaccination site warmth). The reporter stated there was minimal swelling and mild tenderness (Vaccination site swelling, Vaccination site pain). On an unknown date in March 2025, patient also complained of flu like symptoms (Influenza-like illness). The outcome of all events was not reported. The causal relationship between the aforementioned events and Pneumococcal 21-valent Conjugate Vaccine (CAPVAXIVE) was not reported. More
2832607 WI 03/21/2025 HPV9
 MERCK & CO. INC.
No adverse event, Product administered to patient of inappropriate age No adverse event, Product administered to patient of inappropriate age
No additional AE; HCP called to report that a 74-year-old patient was administered a dose of GARDASI... No additional AE; HCP called to report that a 74-year-old patient was administered a dose of GARDASIL 9; This spontaneous report was received from a Pharmacist regarding a 74-year-old patient of unknown gender. The reporter refused to provide information about the patient's medical history, concurrent conditions, concomitant therapies, past drug reactions and allergies. On an unknown date, the patient was vaccinated with Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9), administered as prophylaxis (formulation, dose, vaccination scheme frequency, route of administration, anatomical site of injection, lot number and expiration date were not reported) (Product administered to patient of inappropriate age). No additional adverse event reported for the patient (it was also reported it was unknown if side effects or symptoms were reported, conflicting information). No additional information provided. More
2832608 ID 03/21/2025 VARCEL
 MERCK & CO. INC.
 Y013350
No adverse event, Product storage error No adverse event, Product storage error
No additional AE/No PQC.; HCP calling reporting that a patient has received an improperly stored VAR... No additional AE/No PQC.; HCP calling reporting that a patient has received an improperly stored VARIVAX. Reference TE case #02773596. HCP reported that the VARIVAX underwent a TE on 03/13/2025. HCP reported that the date of the administration was 03/17/2025. No symptoms or; This spontaneous report was received from an other health professional and refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 17-MAR-2025, the patient received improperly stored varicella Virus Vaccine Live (Oka-Merck) (VARIVAX REFRIGERATOR STABLE), Injection, lot #Y013350 and expiration date 02-AUG-2026, 0.5 mL for prophylaxis (dose number, route and site of administration were not provided). The vaccine was reconstituted with sterile diluent (MERCK STERILE DILUENT) (lot number and expiration date were unknown). The excursion lasted for 45 minutes in temperature of 16.1 Fahrenheit degrees. There was previous excursion that lasted 1 hour in temperature of ๏ฟฝ 13.6 Fahrenheit degrees (product storage error). No additional adverse event/ Product Quality Complaints reported (no adverse event). More
2832609 1 KS 03/21/2025 MMR
 MERCK & CO. INC.
 W001598
No adverse event, Product storage error No adverse event, Product storage error
No additional AE reported; MMR II was administered after a temperature excursion; This spontaneous r... No additional AE reported; MMR II was administered after a temperature excursion; This spontaneous report was received from a nurse and refers to a 13-month-old patient of unknown gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 11-JUL-2023 at 10:04, the patient was vaccinated with an improperly stored dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II), lot # W001598, expiration date: 14-JAN-2024 (exact dose, route of administration and anatomical location were not provided) for prophylaxis. The vaccine was reconstituted with sterile diluent (MERCK STERILE DILUENT) (lot # and expiration date were not provided). Administered dose of vaccine was exposed to the temperature excursion of 12.3 degrees Celsius for 6 hours and 23 minutes (product storage error). No previous temperature excursion occurred. There were no additional adverse events reported (no adverse event). This is one of several reports received from the same reporter. More
2832610 8 KS 03/21/2025 MMR
 MERCK & CO. INC.
 W001598
No adverse event, Product storage error No adverse event, Product storage error
No additional AE reported; MMR II was administered after a temperature excursion; This spontaneous r... No additional AE reported; MMR II was administered after a temperature excursion; This spontaneous report was received from a nurse and refers to an 8-year-old patient of unknown gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 06-NOV-2023 at 11:48, the patient was vaccinated with an improperly stored dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II), lot # W001598, expiration date: 14-JAN-2024 (exact dose, route of administration and anatomical location were not provided) for prophylaxis. The vaccine was reconstituted with sterile diluent (MERCK STERILE DILUENT) (lot # and expiration date were not provided). Administered dose of vaccine was exposed to the temperature excursion of 12.3 degrees Celsius for 6 hours and 23 minutes (product storage error). No previous temperature excursion occurred. There were no additional adverse events reported (no adverse event). This is one of several reports received from the same reporter. More
2832611 1 KS 03/21/2025 MMR
 MERCK & CO. INC.
 X011441
No adverse event, Product storage error No adverse event, Product storage error
MMR II was administered after a temperature excursion; No additional AE reported; This spontaneous r... MMR II was administered after a temperature excursion; No additional AE reported; This spontaneous report was received from a nurse and refers to a 20-months-old patient of unknown gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 15-JUL-2024, the patient was vaccinated with an improperly storage dose of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II), lot #X0114411, expiration date expiration date was not reported, however upon internal validation determined as 19-Apr-2024 (exact dose, route of administration and anatomical location were not provided) for prophylaxis. The vaccine was reconstituted with sterile diluent (MERCK STERILE DILUENT) (lot # and expiration date were not provided). Administered dose of vaccine was exposed to the temperature excursion of 12.3 degrees Celsius for 6 hours and 23 minutes (product storage error). No previous temperature excursion occurred. There were no additional adverse events reported (no adverse event). This is one of several reports received from the same reporter.; Reporter's Comments: More
2832612 M CA 03/21/2025 HPV4
HPV4
HPV9
HPV9
 MERCK & CO. INC.
MERCK & CO. INC.
MERCK & CO. INC.
MERCK & CO. INC.



Axillary mass; Axillary mass; Axillary mass; Axillary mass Axillary mass; Axillary mass; Axillary mass; Axillary mass
the son developed a big lump under the armpit; received the first dose of either GARDASIL or GARDASI... the son developed a big lump under the armpit; received the first dose of either GARDASIL or GARDASIL 9 as a teenager approximately 10-12 years ago; received the second dose of the vaccine series, never received the third dose in the series.; This spontaneous report was received from a pharmacist and refers to a male patient of unknown age. The patient's medical history, concurrent conditions, concomitant medications and previous drugs reactions or allergies were not reported. On an unknown date (reported as approximately 10-12 years ago), the patient was vaccinated either with the first dose of human papillomavirus 9-valent vaccine, recombinant suspension for injection (GARDASIL 9) injection, administered as prophylaxis (strength, Lot No., expiration date, dose number, exact dose quantity volume, route and anatomical location of administration and vaccination scheme frequency were not provided); or with the first dose of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine suspension for injection (GARDASIL) injection, administered as prophylaxis (strength, Lot No., expiration date, dose number, exact dose quantity volume, route and anatomical location of administration and vaccination scheme frequency were not provided). On an unknown date, the patient was vaccinated either with the second dose of human papillomavirus 9-valent vaccine, recombinant suspension for injection (GARDASIL 9) injection, administered as prophylaxis (strength, Lot No., expiration date, dose number, exact dose quantity volume, route and anatomical location of administration and vaccination scheme frequency were not provided); or with the second dose of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine suspension for injection (GARDASIL) injection, administered as prophylaxis (strength, Lot No., expiration date, dose number, exact dose quantity volume, route and anatomical location of administration and vaccination scheme frequency were not provided). On an unspecified date (reported as after received the second dose of the vaccine either human papillomavirus 9-valent vaccine, recombinant suspension for injection (GARDASIL 9) or quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine suspension for injection (GARDASIL), the patient experienced big lump under the armpit (axillary mass). It was stated that the patient never received the third dose of the previous mention vaccine either human papillomavirus 9-valent vaccine, recombinant suspension for injection (GARDASIL 9) or quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine suspension for injection (GARDASIL) (inappropriate schedule of product administration) At the time of the reporting, the outcome of the event of axillary mass was not reported. The causal relationship between the event of axillary mass with the suspect vaccines either human papillomavirus 9-valent vaccine, recombinant suspension for injection (GARDASIL 9) or quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine suspension for injection (GARDASIL) was not provided. More
2832613 M 03/21/2025 TDAP
 UNKNOWN MANUFACTURER
 UNK
Autism spectrum disorder Autism spectrum disorder
now he has autism; This serious case was reported by a consumer via call center representative and d... now he has autism; This serious case was reported by a consumer via call center representative and described the occurrence of autism in a male patient who received DTPa (Reduced antigen) (Tdap Vaccine) for prophylaxis. On an unknown date, the patient received Tdap Vaccine. On an unknown date, an unknown time after receiving Tdap Vaccine, the patient experienced autism (Verbatim: now he has autism) (serious criteria GSK medically significant). The outcome of the autism was not resolved. It was unknown if the reporter considered the autism to be related to Tdap Vaccine. The company considered the autism to be unrelated to Tdap Vaccine. Additional Information: GSK Receipt Date: 14-MAR-2025 The patient's mother reported this case. The patient (son) received Tdap vaccine many years ago and now he had autism.; Sender's Comments: Autism spectrum disorder is an unlisted event which is considered unrelated to GSK Tdap Vaccine. More
2832614 03/21/2025 RVX
 UNKNOWN MANUFACTURER
 UNK
Death Death
I would never take a vax again after losing a couple friends within a shot time of receiving the ja... I would never take a vax again after losing a couple friends within a shot time of receiving the jab; This serious case was reported by a consumer via interactive digital media and described the occurrence of unknown cause of death in a patient who received RSVPreF3 adjuvanted (RSV vaccine) for prophylaxis. On an unknown date, the patient received RSV vaccine. On an unknown date, an unknown time after receiving RSV vaccine, the patient experienced unknown cause of death (Verbatim: I would never take a vax again after losing a couple friends within a shot time of receiving the jab) (serious criteria death and GSK medically significant). The reported cause of death was unknown. The reporter considered the unknown cause of death to be related to RSV vaccine. The company considered the unknown cause of death to be unrelated to RSV vaccine. Additional Information: GSK Receipt Date : 19-MAR-2025 This case was reported by a patient via interactive digital media. Reporter reported that she looked into what was in them, she would never took a vaccine again after losing a couple friends within a shot time of received the jab.; Sender's Comments: Death is an unlisted event which is considered unrelated to GSK vaccine RSV vaccine.; Reported Cause(s) of Death: Unknown cause of death More
โœ“
๐Ÿ“‹ Privacy Policy & Data Disclaimer